Page 40 - Product Testing News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Progenity Initiates Safety and Tolerability Study of its Smart Capsule-Based Oral Drug Delivery ... Progenity, Inc.February 17, 2021 GMT SAN DIEGO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing products, today announced the initiation of a clinical study for their D...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Ultragenyx Announces Approval of Dojolvi™ (UX007/triheptanoin) in Canada for the Treatment of ... Ultragenyx Pharmaceutical Inc.February 17, 2021 GMT NOVATO, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today anno...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Addex GABAB Positive Allosteric Modulator Demonstrates Promise in Alcohol Use Disorder Addex TherapeuticsFebruary 16, 2021 GMT Review from Linköping University Published in Alcohol and Alcoholism Journal Geneva, Switzerland, February 16, 2021 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and developm...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Strongbridge Biopharma plc Announces Promotion of Richard S. Kollender to President and Chief ... Strongbridge Biopharma plcFebruary 16, 2021 GMT DUBLIN, Ireland and TREVOSE, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significa...

Press release content from Business Wire. The AP news staff was not involved in its creation. Air Caraïbes and French Bee First Airlines to Pilot ICC AOKpass on Paris to French Overseas Locations Routes February 16, 2021 GMT PARIS--(BUSINESS WIRE)--Feb 16, 2021-- Air Caraïbes and French bee, part of Groupe Dubreuil, have announced the launch of a new pilot of ICC AOKpass, the blockchain based digital health certificate supported by the International Chamber of Commerce (ICC) and global indust...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Basilea reports strong 2020 financial results and significant progress in the clinical pipeline ... Basilea Pharmaceutica AGFebruary 16, 2021 GMT Double-digit growth in Cresemba and Zevtera non-deferred revenue contributions Operating loss reduced by over 50% to CHF 8.2 million Improved operating cash flow by 15%, CHF 167 million year-end cash and financial investments Established clinical proof of co...

Press release content from Business Wire. The AP news staff was not involved in its creation. GenSight Biologics Announces Publication of Results from LUMEVOQ® Phase I/IIa Clinical Trial REVEAL in BioDrugs February 15, 2021 GMT Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. MATEON PARTNERED WITH CHOPRA FOUNDATION ON ARTIVEDA™ Mateon Therapeutics, Inc.February 16, 2021 GMT AGOURA HILLS, California, Feb. 16, 2021 (GLOBE NEWSWIRE) --  Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious disease and respiratory health, announced a global partnership with Chopra Foundation, a non-profit, to collaborat...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured ... LuminosticsFebruary 16, 2021 GMT Luminostics’s Clip COVID Rapid Antigen Test uses a smartphone-based analyzer to obtain results in 30 minutes from nasal swabs in decentralized settings Clip COVID’s emergency use authorization (EUA) in December 2020 closely followed the award of a $26.1 million contract to Lumino...

Press release content from Business Wire. The AP news staff was not involved in its creation. Athersys Announces Cooperation Agreement With HEALIOS K.K. February 16, 2021 GMT CLEVELAND--(BUSINESS WIRE)--Feb 16, 2021-- Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem ® cell therapy, today announced that it has entered into a cooperation agreement with HEALIOS K.K. (“Healios”), the Company’s largest shareholder and one of its commercial partners, and Dr. ...